Banque de Luxembourg Investments (BLI)’s Gilead Sciences GILD Stock Holding History

Banque de Luxembourg Investments (BLI)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.73M	Buy	45,231 +42,700	+1,687%	+$5.63M	0.2%	119
2026 Q1	$307K	Hold	2,531	–	–	0.01%	166
2025 Q4	$312K	Sell	2,531 -8,000	-76%	-$972K	0.01%	169
2025 Q3	$1.19M	Sell	10,531 -9,500	-47%	-$1.08M	0.03%	161
2025 Q2	$2.22M	Sell	20,031 -1,700	-8%	-$181K	0.06%	156
2025 Q1	$2.42M	Sell	21,731 -3,300	-13%	-$341K	0.07%	114
2024 Q4	$2.3M	Buy	+25,031	New	+$2.25M	0.06%	115

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Banque de Luxembourg Investments (BLI)'s GILD Position: Q2 2026 in Review

Banque de Luxembourg Investments (BLI) increased its Gilead Sciences (GILD) stake by 1,687% in Q2 2026, buying an estimated $5.63M and bringing the position to 45,231 shares worth $5.73M. The position accounts for 0.2% of the portfolio, ranked #119.

Banque de Luxembourg Investments (BLI) first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 1,455 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Banque de Luxembourg Investments (BLI) held 45,231 shares of Gilead Sciences worth $5.73M as of Q2 2026.
Banque de Luxembourg Investments (BLI) bought 42,700 Gilead Sciences shares in Q2 2026, an estimated $5.63M.
Gilead Sciences made up 0.2% of Banque de Luxembourg Investments (BLI)'s portfolio in Q2 2026, its #119 holding.
Banque de Luxembourg Investments (BLI) first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
1,455 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q2 2026, filed 10 Aug 2026.